Literature DB >> 15481604

Conformational transitions and glycation of serum albumin in patients with minimal-change glomerulopathy.

Sae Yong Hong1, Eun Young Lee, Jong Oh Yang, Tae Yeong Kim, Eun Hee Kim, Mi Young Cheong, Soo Hyun Kim, Chae Joon Cheong.   

Abstract

BACKGROUND: There has been a lack of study on the structural changes of serum albumin in patients with minimal change disease (MCD). To determine whether glycation and/or conformational transitions of albumin are involved in the pathogenesis of albuminuria, nine patients with MCD were enrolled in a prospective follow-up study for comparison of these parameters in serum albumin during the remission and relapse of nephrotic syndrome.
METHODS: Circular dichroism measurements were made with purified albumin. Ellipticities at each wavelength were transformed to mean residue ellipticity. Monosaccharide composition was analyzed by high-pH anion-exchange chromatography with pulsed amperometric detection.
RESULTS: There was no difference in the proportions of alpha-helix, beta-conformation, and beta-turn of albumin between the sera of control patients and those with nephrotic syndrome. However, the proportion of the random configuration was slightly higher in the plasma albumin of patients in relapse than in those in remission. The proportion of the random configuration was lower in the albumin of the serum than in the urine of patients with nephrotic syndrome, but there was no difference in the proportions of alpha-helix, beta-conformation, and beta-tum of albumin between their plasma and urine.
CONCLUSION: Our results suggest that conformational changes in albumin are involved in albuminuria in patients with MCD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15481604      PMCID: PMC4531563          DOI: 10.3904/kjim.2004.19.3.141

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  27 in total

1.  Fast protein folding on downhill energy landscape.

Authors:  Andrea Cavalli; Urs Haberthür; Emanuele Paci; Amedeo Caflisch
Journal:  Protein Sci       Date:  2003-08       Impact factor: 6.725

Review 2.  Helix capping.

Authors:  R Aurora; G D Rose
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

3.  Micropinocytic ingestion of glycosylated albumin by isolated microvessels: possible role in pathogenesis of diabetic microangiopathy.

Authors:  S K Williams; J J Devenny; M W Bitensky
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

4.  Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse.

Authors:  M P Cohen; N Masson; E Hud; F Ziyadeh; D C Han; R S Clements
Journal:  Exp Nephrol       Date:  2000 May-Jun

5.  Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness.

Authors:  Heike Bantel; M Lienhard Schmitz; Armin Raible; Michael Gregor; Klaus Schulze-Osthoff
Journal:  FASEB J       Date:  2002-09-05       Impact factor: 5.191

6.  Nonenzymatic glycosylation of human serum albumin alters its conformation and function.

Authors:  N Shaklai; R L Garlick; H F Bunn
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

7.  Determination of glomerular size-selectivity in the normal rat with Ficoll.

Authors:  J D Oliver; S Anderson; J L Troy; B M Brenner; W H Deen
Journal:  J Am Soc Nephrol       Date:  1992-08       Impact factor: 10.121

8.  Renal handling of glycated albumin in non-insulin-dependent diabetes mellitus with nephropathy.

Authors:  T Cha; Y Tahara; E Yamato; H Yoneda; H Ikegami; Y Noma; K Shima; T Ogihara
Journal:  Diabetes Res Clin Pract       Date:  1991-07       Impact factor: 5.602

9.  Glycation of albumin, not glomerular basement membrane, alters permeability in an in vitro model.

Authors:  B S Daniels; E B Hauser
Journal:  Diabetes       Date:  1992-11       Impact factor: 9.461

10.  Influence of molecular configuration on the passage of macromolecules across the glomerular capillary wall.

Authors:  M P Bohrer; W M Deen; C R Robertson; J L Troy; B M Brenner
Journal:  J Gen Physiol       Date:  1979-11       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.